| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |